HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shijian Zhang Selected Research

Shijian Zhang Research Topics

Disease

12Infections
01/2022 - 10/2008
5Virus Diseases (Viral Diseases)
12/2020 - 06/2012
3Neoplasms (Cancer)
01/2022 - 12/2018
3COVID-19
01/2022 - 12/2020
3Human Influenza (Influenza)
02/2013 - 11/2011
2Fistula
06/2021 - 01/2020
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 12/2018
1Carcinoma (Carcinomatosis)
01/2022
1Shock
10/2021
1Hepatitis C
02/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2013
1Influenza in Birds (Avian Flu)
06/2012
1Abscess
03/2011
1Bacterial Infections (Bacterial Infection)
03/2011

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
01/2022 - 02/2013
4Neutralizing AntibodiesIBA
01/2022 - 12/2020
4Glycoproteins (Glycoprotein)IBA
01/2022 - 08/2015
3ciprofloxacin dithiocarbamateIBA
03/2011 - 10/2008
2Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2018
2Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2011
2AmylasesFDA Link
06/2021 - 01/2020
2AntibodiesIBA
01/2020 - 08/2015
2DNA-Directed RNA Polymerases (RNA Polymerase)IBA
02/2013 - 06/2012
1Long Noncoding RNAIBA
01/2022
1alectinibIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1CD4 Antigens (CD4 Antigen)IBA
11/2021
1TungstenIBA
10/2021
1COVID-19 VaccinesIBA
12/2020
1PF 68742IBA
11/2019
1Hematoxylin (Haematoxylon)IBA
01/2019
1Interleukin-17 (Interleukin 17)IBA
01/2019
1Eosine Yellowish-(YS) (Eosin)IBA
01/2019
1isothiocyanic acidIBA
02/2013
1Antiviral Agents (Antivirals)IBA
02/2013
1Fluorescein (Funduscein)FDA LinkGeneric
02/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2013
1Tripartite Motif ProteinsIBA
01/2013
1InterferonsIBA
06/2012
1Caspase 3 (Caspase-3)IBA
06/2012
1Peptides (Polypeptides)IBA
11/2011
1Pharmaceutical PreparationsIBA
11/2011
1Human Immunodeficiency Virus tat Gene ProductsIBA
11/2011
1Proline (L-Proline)FDA Link
11/2011
1norfloxacin dithiocarbamateIBA
03/2011
1Ciprofloxacin (Cipro)FDA LinkGeneric
03/2011
1TurpentineIBA
03/2011
1Biological ProductsIBA
06/2010

Therapy/Procedure

3Therapeutics
01/2022 - 12/2018